市场调查报告书
商品编码
1454043
到 2030 年医疗保健市场中的 eConsent 预测:按平台、註册类型、表格类型、应用程式、最终用户和地区进行的全球分析EConsent in Healthcare Market Forecasts to 2030 - Global Analysis By Platform (Web-Based and Cloud-Based), Enrollment Type, Form Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球医疗保健电子同意市场规模为 4.321 亿美元,预计到 2030 年将达到 10.356 亿美元,预测期内复合年增长率为 13.3%。
在医疗保健领域,电子同意是指患者使用数位平台和电子系统对医疗保健行动、程序和参与研究提供知情同意的电子流程。使用电子签章、线上表单和数位文件安全地捕获和储存患者同意请求。它旨在简化同意流程,使患者和医疗保健提供者更有效率、更方便。这使得患者可以在电子同意之前按照自己的步调在线查看有关治疗选择、风险、益处和替代方案的资讯。
根据Signant Health 的「2020 年eConsent 状况」报告,28% 的受访者已将eConsent 与EDC 产品或临床试验管理系统集成,分别有17%、19% 和26% 的受访者已将eConsent 与EDC产品整合或临床试验管理系统。- 与临床实验药物供应管理解决方案、电子临床实验主文件和电子临床结果评估整合。
更多采用电子健康记录(EHR)
医疗保健产业正在见证电子健康记录(EHR) 的快速采用,特别是在电子同意领域。这种整合简化了同意流程,并为患者管理其医疗保健决策提供了更大的可及性和透明度。这种向数位同意的转变不仅提高了效率,而且增强了患者的参与度,同时确保遵守监管标准。因此,在技术普及的推动下,市场正经历显着成长。
资料安全和隐私问题
随着敏感的患者资讯变得数位化并以电子方式共用,人们担心未授权存取、资料外洩和滥用个人医疗保健资料的可能性。确保强大的加密通讯协定、严格的存取控制以及遵守严格的隐私法规至关重要。加密措施不足和网路威胁防护措施不足是主要挑战。
扩大数位健康工作
医疗保健领域的数位健康计划显着扩展,特别是电子同意解决方案的整合。透过利用行动应用程式和基于网路的入口网站等数位平台,患者可以轻鬆地远端存取、审查和签署同意书。这不仅提高了效率,还确保符合监管要求,并促进患者参与医疗保健决策流程并赋予其权力。
初始实施成本
市场上的初始实施成本取决于医疗机构的规模、系统的复杂性以及所需的客製化等级等因素。包括与软体许可、硬体基础设施、员工培训、与现有系统整合以及遵守监管标准相关的成本。因此,这些都是阻碍市场成长的因素。
COVID-19 的疫情对医疗保健领域的电子同意市场产生了重大影响。由于需要减少社交距离和尽量减少身体接触,医疗保健提供者越来越多地采用电子同意解决方案,以促进远距患者互动。这一转变加速了医疗保健领域的数位转型,并导致更多地采用 eConsent 平台来获取患者对治疗、手术和临床试验的同意。此次疫情凸显了高效、安全和可存取的同意流程的重要性,推动了医疗保健领域电子同意市场的成长。
预计普遍同意部分在预测期内将是最大的
在预测期内,一般同意部分预计将是最大的。这些平台上的普遍同意通常包括患者授予的常规医疗保健活动、治疗和健康资讯揭露的广泛许可。透过数位化同意流程,eConsent 解决方案提高了效率、准确性和合规性,同时使患者能够就其护理做出明智的决定。
预计临床试验部分在预测期内复合年增长率最高。
预计临床试验部分在预测期内复合年增长率最高。这种数位方法简化了同意流程,并提供了诸如提高参与者理解、远端存取和即时追踪等优势。随着技术的发展,eConsent 系统整合预计将透过提高参与者招募和同意流程的效率和透明度来扩展和彻底改变临床试验格局。
预计北美在预测期内将占据最大的市场占有率。 eConsent 工具提供了更大的便利性和可近性,可提高患者的参与和理解,同时确保遵守监管标准。凭藉电子签章和互动式多媒体等功能,这些解决方案提高了透明度,促进明智的决策,并最终提高整体医疗保健领域的效率和课责。Masu。
预计亚太地区在预测期内的复合年增长率最高。 eConsent 解决方案具有多种优势,例如增加可访问性、加强患者教育以及提高同意流程的透明度。随着医疗保健组织认识到数位解决方案在改善患者照护、提高业务效率和确保监管合规性方面的价值,预计该市场的采用率将继续增长。
According to Stratistics MRC, the Global EConsent in Healthcare Market is accounted for $432.1 million in 2023 and is expected to reach $1035.6 million by 2030 growing at a CAGR of 13.3% during the forecast period. EConsent in healthcare refers to the electronic process through which patients provide their informed consent for medical treatment, procedures, or participation in research studies using digital platforms or electronic systems. It encompasses the use of electronic signatures, online forms, and digital documentation to capture and store patients' consent preferences securely. It aims to streamline the consent process, making it more efficient and accessible for both patients and healthcare providers. It allows patients to review information about their treatment options, risks, benefits, and alternatives online, at their own pace, before consenting electronically.
According to the State of eConsent 2020 report by Signant Health, 28% of survey respondents integrated eConsent with EDC products and clinical trial management systems, while 17%, 19%, and 26% integrated eConsent with randomization & trial supply management solutions, electronic trial master file, and electronic clinical outcome assessment, respectively.
Increased adoption of electronic health records (EHRs)
The healthcare industry is witnessing a surge in the adoption of electronic health records (EHRs), particularly in the realm of EConsent. The integration streamlines the consent process, offering patients greater accessibility and transparency in managing their healthcare decisions. This shift towards digital consent not only enhances efficiency but also ensures compliance with regulatory standards while bolstering patient engagement. As a result, the market is experiencing significant growth propelled by the widespread embrace of technology.
Concerns about data security and privacy
With sensitive patient information being digitized and shared electronically, there are worries about unauthorized access, data breaches, and potential misuse of personal health data. Ensuring robust encryption protocols, stringent access controls, and compliance with stringent privacy regulations is imperative. Insufficient encryption measures and inadequate safeguards against cyber threats pose significant challenges.
Expansion of digital health initiatives
The healthcare sector has seen a significant expansion of digital health initiatives, particularly in the integration of electronic consent solutions. By leveraging digital platforms, such as mobile apps or web-based portals, patients can conveniently access, review, and sign consent forms remotely. This not only improves efficiency but also ensures compliance with regulatory requirements while promoting patient engagement and empowerment in their healthcare decision-making process.
Initial implementation costs
The initial implementation costs in the market can vary depending on factors such as the size of the healthcare organization, the complexity of the system, and the level of customization required. They encompass expenses related to software licensing, hardware infrastructure, staff training, integration with existing systems, and compliance with regulatory standards. Hence, these are the factors hampering the growth of the market.
The COVID-19 pandemic has significantly impacted the eConsent in healthcare market. With social distancing measures and the need to minimize physical contact, healthcare providers are increasingly adopting electronic consent solutions to facilitate remote patient interactions. This shift has accelerated the digital transformation in healthcare, leading to greater adoption of eConsent platforms for obtaining patient consent for treatments, procedures, and clinical trials. The pandemic has underscored the importance of efficient, secure, and accessible consent processes, driving the growth of the eConsent market in healthcare.
The general consent segment is expected to be the largest during the forecast period
The general consent segment is expected to be the largest during the forecast period. General consent within these platforms typically encompasses broad permissions granted by patients for routine healthcare activities, treatments, and disclosures of health information. By digitizing the consent process, eConsent solutions enhance efficiency, accuracy, and compliance while empowering patients to make informed decisions about their care.
The clinical trails segment is expected to have the highest CAGR during the forecast period
The clinical trails segment is expected to have the highest CAGR during the forecast period. This digital approach streamlines the consent process, offering benefits such as enhanced participant comprehension, remote access, and real-time tracking. As technology evolves, the integration of eConsent systems is anticipated to grow, revolutionizing the clinical trial landscape by enhancing efficiency and transparency in participant recruitment and consent processes.
North America is projected to hold the largest market share during the forecast period. Offering greater convenience and accessibility, eConsent tools enhance patient engagement and comprehension while ensuring compliance with regulatory standards. With features like electronic signatures and interactive multimedia, these solutions improve transparency and facilitate informed decision-making, ultimately fostering efficiency and accountability across the healthcare continuum.
Asia Pacific is projected to hold the highest CAGR over the forecast period. Data security and privacy are paramount concerns in the adoption of eConsent solutions. eConsent solutions offer benefits such as improved accessibility, enhanced patient education, and greater transparency in the consent process. The adoption in the market is expected to continue growing as healthcare organizations recognize the value of digital solutions in improving patient care, enhancing operational efficiency, and ensuring regulatory compliance.
Key players in the market
Some of the key players in EConsent in Healthcare market include Citadel Group, Veeva Systems, Thieme Compliance GmbH, Wellbeing Software, Interlace Health, Florence Healthcare, 5thPort, LLC, Adobe Inc., Concentric Health Ltd, GE Healthcare, Koninklijke Philips N.V., HealthStream Inc., Cerner Corporation, Medtronic, Siemens Healthineers and ClinOne.
In June 2022, uMotif and ClinOne announced a partnership to address the challenges faced by patients & clinical research coordinators who struggle to navigate multiple systems, apps, & sensors for each protocol.
In October 2020, Veeva Systems launched two new applications built on Veeva Clinical Network - Veeva Site Connect and Veeva eConsent.